Everest Organics
EVERESTOBSE

Everest Organics

₹252.35-8.40 (3.22%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
247.10
Today’s high
266.65
52 week low
197.00
52 week high
536.40
Open price
260.80
Previous close
260.75
Live volume
1,863
Lower circuit
208.60
Upper circuit
312.90

Fundamentals

Market Cap
₹253Cr
ROE
0.00%
P/E Ratio(TTM)
43.46
EPS(TTM)
6.00
P/B Ratio
3.49
Dividend Yield
0.00%
Industry P/E
42.82
Book Value
74.67
Debt to Equity
0.00
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹42.84
-16.47%
Profit (Cr)
₹0.36
-68.97%
015304560
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+2%
3Y CAGR-7.0%
Profit growthValue
1Y (TTM)-68%

About

Everest Organics Limited has been engaged in manufacturing Active Pharmaceutical Ingredients and Intermediates for the chemical and pharma industries for approximately three decades. The company's primary mission is to deliver high-quality APIs and intermediates that support the global healthcare ecosystem and make a meaningful industry impact. It remains deeply committed to sustainability and corporate responsibility by minimizing its environmental footprint and upholding high ethical standards in all business aspects. A key part of its strategy involves investing in state-of-the-art technology and upgrading facilities to improve its manufacturing processes for a competitive edge. The company's research and development efforts are focused not just on staying competitive but also on contributing to the advancement of healthcare itself. Demonstrating strong performance, the company registered a total revenue of ₹19,812.74 Lakhs, marking an increase over the previous corresponding year.;
CEO/MD
Dr. Srikakarlapudi Sirisha
Founded in
1993
BSE symbol
524790

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
59.58%
Retail And Others
40.40%
Other Domestic Institutions
0.02%
2026
11
Feb
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
5
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks